Atlas Trials

A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers

Clinical trial NCT02082327 · COMPLETED

Trial details

NCT number
NCT02082327
Sponsor
Amicus Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fabry Disease
Start date
2014-03-01
Primary completion
2014-06-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.